These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9033723)

  • 1. [Light and heavy chain deposition disease with cutaneous and renal manifestations].
    Safa G; Dhib M; Soubrane JC; Thomine E; Delpech A; François A; Joly P; Lauret P
    Ann Dermatol Venereol; 1996; 123(8):490-2. PubMed ID: 9033723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-amyloidotic glomerular disease caused by light-chain deposits: a case report].
    Cantillo Jde J; López Rdel P; Andrade RE
    Biomedica; 2009 Dec; 29(4):531-8. PubMed ID: 20440451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
    Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
    Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Light chain deposition disease].
    Terzani E; Alterini B; Doni M; Lampronti V; Lusini C; Fazzini G
    Ann Ital Med Int; 1994; 9(2):100-4. PubMed ID: 7917761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
    Gallo G; Picken M; Frangione B; Buxbaum J
    Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.
    Yasuda T; Fujita K; Imai H; Morita K; Nakamoto Y; Miura AB
    Clin Nephrol; 1995 Dec; 44(6):394-9. PubMed ID: 8719552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.
    Tubbs RR; Berkley V; Valenzuela R; McMahon JT; Gephardt GN; Fishleder AJ; Nally JV; Pohl MA; Bukowski RM; Lichtin AE
    Mod Pathol; 1992 Mar; 5(2):185-90. PubMed ID: 1574496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case report of light and heavy chain deposition disease (IgG2 lambda)].
    Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oshikawa Y; Oda T; Suzuki Y; Shimizu J
    Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1057-66. PubMed ID: 7967178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal involvement in monoclonal (type I) cryoglobulinemia: two cases associated with IgG3 kappa cryoglobulin.
    Karras A; Noël LH; Droz D; Delansorne D; Saint-André JP; Aucouturier P; Alyanakian MA; Grünfeld JP; Lesavre P
    Am J Kidney Dis; 2002 Nov; 40(5):1091-6. PubMed ID: 12407656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG heavy-chain deposition disease.
    Katz A; Zent R; Bargman JM
    Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal free light chains can be found in heavy chain diseases.
    López-Anglada L; Puig N; Díez-Campelo M; Alonso-Ralero L; Barrena S; Aparicio MA; Gutiérrez NC; García-Sanz R
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):570-2. PubMed ID: 20930031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heavy chain deposition disease: report of a case and review of the literature].
    Imai H
    Rinsho Byori; 2001 Jul; 49(7):695-8. PubMed ID: 11519134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
    Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
    Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
    van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
    Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal immunoglobulin deposition disease associated with membranous features.
    Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concurrence of light and heavy chain deposition disease and diabetic nephropathy.
    Satirapoj B; Paueksakon P
    J Med Assoc Thai; 2007 Oct; 90(10):2204-8. PubMed ID: 18041443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis.
    Grove P; Neale PH; Peck M; Schiller B; Haas M
    Mod Pathol; 1998 Jan; 11(1):103-9. PubMed ID: 9556416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.